サンバイオの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/12/20 | 3,105 | 3,235 | 3,050 | 3,140 | +50 | +1.6% | 296,300 |
2017/12/19 | 3,150 | 3,210 | 3,000 | 3,090 | -55 | -1.7% | 489,500 |
2017/12/18 | 3,330 | 3,340 | 3,065 | 3,145 | -170 | -5.1% | 713,100 |
2017/12/15 | 3,365 | 3,440 | 3,230 | 3,315 | -45 | -1.3% | 780,900 |
2017/12/14 | 3,220 | 3,430 | 3,040 | 3,360 | +245 | +7.9% | 1,425,800 |
2017/12/13 | 3,050 | 3,300 | 3,040 | 3,115 | +65 | +2.1% | 886,100 |
2017/12/12 | 3,010 | 3,130 | 2,996 | 3,050 | +20 | +0.7% | 310,300 |
2017/12/11 | 3,070 | 3,085 | 2,994 | 3,030 | ±0 | ±0% | 239,800 |
2017/12/08 | 2,985 | 3,040 | 2,910 | 3,030 | -20 | -0.7% | 588,900 |
2017/12/07 | 3,140 | 3,190 | 2,984 | 3,050 | +35 | +1.2% | 551,300 |
2017/12/06 | 3,000 | 3,170 | 2,898 | 3,015 | +127 | +4.4% | 1,108,400 |
2017/12/05 | 3,015 | 3,040 | 2,873 | 2,888 | -167 | -5.5% | 875,500 |
2017/12/04 | 2,875 | 3,220 | 2,865 | 3,055 | +252 | +9% | 1,307,000 |
2017/12/01 | 2,810 | 2,853 | 2,768 | 2,803 | -3 | -0.1% | 357,100 |
2017/11/30 | 2,810 | 2,870 | 2,754 | 2,806 | +1 | ±0% | 824,200 |
2017/11/29 | 2,610 | 2,823 | 2,610 | 2,805 | +196 | +7.5% | 1,261,200 |
2017/11/28 | 2,578 | 2,648 | 2,512 | 2,609 | +25 | +1% | 356,500 |
2017/11/27 | 2,533 | 2,688 | 2,530 | 2,584 | +51 | +2% | 767,500 |
2017/11/24 | 2,782 | 2,812 | 2,503 | 2,533 | -232 | -8.4% | 1,368,800 |
2017/11/22 | 2,664 | 2,794 | 2,657 | 2,765 | +126 | +4.8% | 883,500 |
2017/11/21 | 2,511 | 2,646 | 2,485 | 2,639 | +106 | +4.2% | 948,800 |
2017/11/20 | 2,382 | 2,570 | 2,371 | 2,533 | +145 | +6.1% | 1,282,600 |
2017/11/17 | 2,241 | 2,419 | 2,220 | 2,388 | +177 | +8% | 1,197,000 |
2017/11/16 | 2,050 | 2,226 | 2,044 | 2,211 | +168 | +8.2% | 995,800 |
2017/11/15 | 2,084 | 2,129 | 2,022 | 2,043 | -24 | -1.2% | 416,500 |
2017/11/14 | 2,092 | 2,098 | 2,050 | 2,067 | -25 | -1.2% | 209,100 |
2017/11/13 | 2,084 | 2,123 | 2,070 | 2,092 | +9 | +0.4% | 194,900 |
2017/11/10 | 2,030 | 2,099 | 2,006 | 2,083 | +40 | +2% | 301,900 |
2017/11/09 | 2,140 | 2,140 | 2,009 | 2,043 | -97 | -4.5% | 511,700 |
2017/11/08 | 2,090 | 2,149 | 2,058 | 2,140 | +55 | +2.6% | 367,800 |
2017/11/07 | 2,117 | 2,205 | 1,988 | 2,085 | -20 | -1% | 790,500 |
2017/11/06 | 2,122 | 2,167 | 2,058 | 2,105 | -67 | -3.1% | 487,100 |
2017/11/02 | 2,261 | 2,263 | 2,073 | 2,172 | -74 | -3.3% | 715,600 |
2017/11/01 | 2,140 | 2,297 | 2,135 | 2,246 | +152 | +7.3% | 1,538,400 |
2017/10/31 | 2,100 | 2,137 | 2,062 | 2,094 | -26 | -1.2% | 525,800 |
2017/10/30 | 2,011 | 2,140 | 2,001 | 2,120 | +132 | +6.6% | 729,600 |
2017/10/27 | 1,982 | 2,020 | 1,981 | 1,988 | +4 | +0.2% | 306,900 |
2017/10/26 | 1,900 | 2,037 | 1,894 | 1,984 | +73 | +3.8% | 743,800 |
2017/10/25 | 1,950 | 1,995 | 1,903 | 1,911 | -45 | -2.3% | 434,600 |
2017/10/24 | 1,930 | 1,973 | 1,896 | 1,956 | -2 | -0.1% | 542,900 |
2017/10/23 | 1,820 | 1,978 | 1,813 | 1,958 | +150 | +8.3% | 586,000 |
2017/10/20 | 1,785 | 1,868 | 1,757 | 1,808 | -11 | -0.6% | 590,000 |
2017/10/19 | 1,888 | 1,897 | 1,794 | 1,819 | -68 | -3.6% | 628,300 |
2017/10/18 | 1,915 | 1,931 | 1,857 | 1,887 | -31 | -1.6% | 448,100 |
2017/10/17 | 2,070 | 2,124 | 1,807 | 1,918 | -160 | -7.7% | 1,647,600 |
2017/10/16 | 2,100 | 2,130 | 2,027 | 2,078 | -6 | -0.3% | 1,007,400 |
2017/10/13 | 1,920 | 2,088 | 1,891 | 2,084 | +174 | +9.1% | 1,369,000 |
2017/10/12 | 1,931 | 1,950 | 1,905 | 1,910 | -3 | -0.2% | 322,900 |
2017/10/11 | 1,917 | 1,967 | 1,889 | 1,913 | -10 | -0.5% | 695,300 |
2017/10/10 | 1,870 | 1,969 | 1,860 | 1,923 | +93 | +5.1% | 1,092,000 |
1801~
1850
件表示中 / 2464件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サンバイオ | 240,900円 | - | - | 0.00% | - | 111.58倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
科研薬 | 386,700円 | +30.5% | +111.0% | 4.91% | 10.90倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 261,300円 | +13.9% | +6.6% | 2.68% | 6.81倍 | 0.81倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ジーエヌアイ | 237,400円 | +21.7% | +999.9% | 0.00% | 9.89倍 | 3.27倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム